Evidence map›Paper›PMID 31140414›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2019

[Effects of mitochondrial aldehyde dehydrogenase 2 on autophagy-associated proteins in neonatal rat myocardial fibroblasts cultured in high glucose].

Bi Tang, Pinfang Kang, Jianlu Guo, Lei Zhu, Qingmei Xu, Qin Gao, Heng Zhang, Hongju Wang

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Metabolic disease and the liver: A review.World journal of hepatology · 2024
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bi TangDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Pinfang KangDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Jianlu GuoDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Lei ZhuDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Qingmei XuDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Qin GaoDepartment of Physiology Cardiovascular Research Center of BengBu Medical College, Bengbu 233030, China.
Heng ZhangDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Hongju WangDepartment of Cardiovascular Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether autophagy mediates the effects of aldehyde dehydrogenase 2 (ALDH2) on the proliferation of neonatal rat cardiac fibroblasts cultured in high glucose.

methodsCardiac fibroblasts were isolated from neonatal (within 3 days) SD rats and subcultured. The fibroblasts of the third passage, after identification with immunofluorescence staining for vimentin, were treated with 5.5 mmol/L glucose (control group), 30 mmol/L glucose (high glucose group), or 30 mmol/L glucose in the presence of Alda-1 (an ALDH2 agonist), daidzin (an ALDH2 2 inhibitor), or both. Western blotting was employed to detect ALDH2, microtubule-associated protein 1 light chain 3B subunit (LC3B) and Beclin-1 in the cells, and a hydroxyproline detection kit was used for determining hydroxyproline content in cell culture medium; CCK- 8 kit was used for assessing the proliferation ability of the cardiac fibroblasts after the treatments.

resultsCompared with the control cells, the cells exposed to high glucose exhibited obviously decreased expressions of ALDH2, Beclin-1 and LC3B and increased cell number and hydroxyproline content in the culture medium. Treatment of the high glucose-exposed cells with Alda-1 significantly increased Beclin-1, LC3B, and ALDH2 protein expressions and lowered the cell number and intracellular hydroxyproline content, whereas the application of daidzin resulted in reverse changes in the expressions of ALDH2, Beclin-1 and LC3B, viable cell number and intracellular hydroxyproline content in high glucose-exposed cells.

conclusionsMitochondrial ALDH2 inhibits the proliferation of neonatal rat cardiac fibroblasts induced by high glucose, and the effect is possibly mediated by the up-regulation of autophagy-related proteins Beclin-1 and LC3B.

Indexed as

Aldehyde Dehydrogenase, MitochondrialAutophagyAldehyde DehydrogenaseAnimalsAnimals, NewbornBeclin-1FibroblastsGlucoseMicrotubule-Associated ProteinsMitochondrial ProteinsRatsRats, Sprague-DawleyAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAldh2 protein, ratAnxa3 protein, ratBeclin-1Becn1 protein, ratGlucoseMicrotubule-Associated ProteinsMitochondrial Proteinsautophagyhigh glucosemitochondrial acetaldehyde dehydrogenase 2

Identifiers

PMID31140414
PMCPMC6743934
OpenAlexW3025844812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.